Form 4 for HALO HALOZYME THERAPEUTICS, INC.
Accepted 2024-02-13 00:00:00 ET · period of report 2024-02-10 · accession 0001415889-24-003517 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-02-13 | 2024-02-10 | HALO | Torley Helen | Pres AND CEO, Dir | M - OptEx | $0.00 | +31.3K | 654.9K | +5% | $0 |
| D | 2024-02-13 | 2024-02-10 | HALO | Torley Helen | Pres AND CEO, Dir | F - Tax | $35.49 | -16.9K | 638.0K | -3% | -$601.3K |
| D | 2024-02-13 | 2024-02-10 | HALO | Torley Helen | Pres AND CEO, Dir | M - OptEx | $0.00 | -31.3K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-10 | M | A | 31,281 | $0.00 | 654,947 | D | — | — | |
| 2 | Common | Common Stock | 2024-02-10 | F | D | 16,943 | $35.49 | 638,004 | D | — | — | (F1) The reported disposition of 16,943 shares represents the shares that were withheld by the issuer as payment for minimum statutory tax withholding obligations. |
| 3 | Derivative | Restricted Stock Units | 2024-02-10 | M | D | 31,281 | $0.00 | 0 | D | $0.00 · — to — | 31,281 Common Stock | (F2) This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer. |